MAP2K7 and melanoma: Inhibition of BRAF/MEK signaling by silencer (si)RNA and pharmacological inhibition decreased the production of pro-tumorigenic factors such as IL-1α/β [46], IL-6 [43], IL-8 [48], IL-10 [43,49], and VEGF [43,50] by melanoma cells.